-
Je něco špatně v tomto záznamu ?
Prognostic value of the 5-SENSE Score to predict focality of the seizure-onset zone as assessed by stereoelectroencephalography: a prospective international multicentre validation study
A. Astner-Rohracher, A. Ho, J. Archer, F. Bartolomei, M. Brazdil, M. Cacic Hribljan, J. Castellano, I. Dolezalova, ME. Fabricius, M. Garcés-Sanchez, K. Hammam, A. Ikeda, K. Ikeda, P. Kahane, G. Kalamangalam, G. Kalss, M. Khweileh, K. Kobayashi,...
Status neindexováno Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2019
PubMed Central
od 2019
ProQuest Central
od 2019-07-01
Health & Medicine (ProQuest)
od 2019-07-01
ROAD: Directory of Open Access Scholarly Resources
od 2019
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Epilepsy surgery is the only curative treatment for patients with drug-resistant focal epilepsy. Stereoelectroencephalography (SEEG) is the gold standard to delineate the seizure-onset zone (SOZ). However, up to 40% of patients are subsequently not operated as no focal non-eloquent SOZ can be identified. The 5-SENSE Score is a 5-point score to predict whether a focal SOZ is likely to be identified by SEEG. This study aims to validate the 5-SENSE Score, improve score performance by incorporating auxiliary diagnostic methods and evaluate its concordance with expert decisions. METHODS AND ANALYSIS: Non-interventional, observational, multicentre, prospective study including 200 patients with drug-resistant epilepsy aged ≥15 years undergoing SEEG for identification of a focal SOZ and 200 controls at 22 epilepsy surgery centres worldwide. The primary objective is to assess the diagnostic accuracy and generalisability of the 5-SENSE in predicting focality in SEEG in a prospective cohort. Secondary objectives are to optimise score performance by incorporating auxiliary diagnostic methods and to analyse concordance of the 5-SENSE Score with the expert decisions made in the multidisciplinary team discussion. ETHICS AND DISSEMINATION: Prospective multicentre validation of the 5-SENSE score may lead to its implementation into clinical practice to assist clinicians in the difficult decision of whether to proceed with implantation. This study will be conducted in accordance with the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (2014). We plan to publish the study results in a peer-reviewed full-length original article and present its findings at scientific conferences. TRIAL REGISTRATION NUMBER: NCT06138808.
Biostatistics and Big Medical Data Paracelsus Medical Private University Salzburg Austria
Clinical Medicine University of Copenhagen Faculty of Health and Medical Sciences Kobenhavn Denmark
Clinical Neurophysiology Aarhus University Hospital Aarhus Denmark
Clinical Neurophysiology Rigshospitalet Kobenhavn Denmark
Epilepsy Centre University Hospital Freiburg Department of Neurology Freiburg im Breisgau Germany
Monash University Clayton Victoria Australia
Neurology Aix Marseille Universite Marseille France
Neurology Alfred Hospital Melbourne Victoria Australia
Neurology Dalhousie University Faculty of Medicine Halifax Nova Scotia Canada
Neurology Duke University Durham North Carolina USA
Neurology Grenoble Alpes University Hospital Grenoble France
Neurology Hospital del Mar Barcelona Spain
Neurology Hospital Universitari i Politècnic La Fe Valencia Spain
Neurology Kyoto University Graduate School of Medicine Faculty of Medicine Kyoto Japan
Neurology Masaryk University Faculty of Medicine Brno Czech Republic
Neurology Medical University of Innsbruck Department of Neurology and Neurosurgery Innsbruck Austria
Neurology Montreal Neurological Institute Hospital Montreal Quebec Canada
Neurology Paracelsus Medical University Salzburg Salzburg Austria
Neurology University of Florida Gainesville Florida USA
Neurology University of Medicine and Pharmacy Carol Davila Bucharest Bucuresti Romania
Neurology University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA
Neurology University of Texas McGovern Medical School Houston Texas USA
Neurology Western University Schulich School of Medicine and Dentistry London Ontario Canada
Neurosciences Mater Hospital Brisbane Brisbane Queensland Australia
Northwestern University Feinberg School of Medicine Chicago Illinois USA
Service de Neurophysiologie Clinique INSERM U751 CHU Timone Marseille France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24017991
- 003
- CZ-PrNML
- 005
- 20241016081810.0
- 007
- ta
- 008
- 241008s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/bmjno-2024-000765 $2 doi
- 035 __
- $a (PubMed)39175939
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Astner-Rohracher, Alexandra $u Neurology, Medical University of Innsbruck Department of Neurology and Neurosurgery, Innsbruck, Austria $1 https://orcid.org/000000021132302X
- 245 10
- $a Prognostic value of the 5-SENSE Score to predict focality of the seizure-onset zone as assessed by stereoelectroencephalography: a prospective international multicentre validation study / $c A. Astner-Rohracher, A. Ho, J. Archer, F. Bartolomei, M. Brazdil, M. Cacic Hribljan, J. Castellano, I. Dolezalova, ME. Fabricius, M. Garcés-Sanchez, K. Hammam, A. Ikeda, K. Ikeda, P. Kahane, G. Kalamangalam, G. Kalss, M. Khweileh, K. Kobayashi, P. Kwan, JA. Laing, M. Leitinger, S. Lhatoo, J. Makhalova, A. McGonigal, I. Mindruta, MM. Mizera, A. Neal, I. Oane, P. Parikh, P. Perucca, F. Pizzo, R. Rocamora, P. Ryvlin, V. San Antonio Arce, S. Schuele, A. Schulze-Bonhage, A. Suller Marti, A. Urban, V. Villanueva, L. Vilella Bertran, B. Whatley, S. Beniczky, E. Trinka, G. Zimmermann, B. Frauscher
- 520 9_
- $a INTRODUCTION: Epilepsy surgery is the only curative treatment for patients with drug-resistant focal epilepsy. Stereoelectroencephalography (SEEG) is the gold standard to delineate the seizure-onset zone (SOZ). However, up to 40% of patients are subsequently not operated as no focal non-eloquent SOZ can be identified. The 5-SENSE Score is a 5-point score to predict whether a focal SOZ is likely to be identified by SEEG. This study aims to validate the 5-SENSE Score, improve score performance by incorporating auxiliary diagnostic methods and evaluate its concordance with expert decisions. METHODS AND ANALYSIS: Non-interventional, observational, multicentre, prospective study including 200 patients with drug-resistant epilepsy aged ≥15 years undergoing SEEG for identification of a focal SOZ and 200 controls at 22 epilepsy surgery centres worldwide. The primary objective is to assess the diagnostic accuracy and generalisability of the 5-SENSE in predicting focality in SEEG in a prospective cohort. Secondary objectives are to optimise score performance by incorporating auxiliary diagnostic methods and to analyse concordance of the 5-SENSE Score with the expert decisions made in the multidisciplinary team discussion. ETHICS AND DISSEMINATION: Prospective multicentre validation of the 5-SENSE score may lead to its implementation into clinical practice to assist clinicians in the difficult decision of whether to proceed with implantation. This study will be conducted in accordance with the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (2014). We plan to publish the study results in a peer-reviewed full-length original article and present its findings at scientific conferences. TRIAL REGISTRATION NUMBER: NCT06138808.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ho, Alyssa $u Neurology, Duke University, Durham, North Carolina, USA
- 700 1_
- $a Archer, John $u Bladin-Berkovic Comprehensive Epilepsy Program, The University of Melbourne Medicine at Austin Health, Heidelberg, Victoria, Australia
- 700 1_
- $a Bartolomei, Fabrice $u Service de Neurophysiologie Clinique, INSERM U751, CHU Timone, Marseille, France $u Neurology, Aix-Marseille Universite, Marseille, France $1 https://orcid.org/0000000216780297
- 700 1_
- $a Brazdil, Milan $u Neurology, Masaryk University Faculty of Medicine, Brno, Czech Republic
- 700 1_
- $a Cacic Hribljan, Melita $u Clinical Neurophysiology, Rigshospitalet, Kobenhavn, Denmark
- 700 1_
- $a Castellano, James $u Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- 700 1_
- $a Dolezalova, Irena $u Neurology, Masaryk University Faculty of Medicine, Brno, Czech Republic
- 700 1_
- $a Fabricius, Martin Ejler $u Clinical Neurophysiology, Rigshospitalet, Kobenhavn, Denmark $u Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Kobenhavn, Denmark
- 700 1_
- $a Garcés-Sanchez, Mercedes $u Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
- 700 1_
- $a Hammam, Kahina $u Neurology, Aix-Marseille Universite, Marseille, France
- 700 1_
- $a Ikeda, Akio $u Neurology, Kyoto University Graduate School of Medicine Faculty of Medicine, Kyoto, Japan
- 700 1_
- $a Ikeda, Kristin $u Neurology, Dalhousie University Faculty of Medicine, Halifax, Nova Scotia, Canada
- 700 1_
- $a Kahane, Philippe $u Neurology, Grenoble Alpes University Hospital, Grenoble, France
- 700 1_
- $a Kalamangalam, Giridhar $u Neurology, University of Florida, Gainesville, Florida, USA
- 700 1_
- $a Kalss, Gudrun $u Neurology, Paracelsus Medical University Salzburg, Salzburg, Austria
- 700 1_
- $a Khweileh, Mays $u Neurology, Duke University, Durham, North Carolina, USA
- 700 1_
- $a Kobayashi, Katsuya $u Neurology, Kyoto University Graduate School of Medicine Faculty of Medicine, Kyoto, Japan
- 700 1_
- $a Kwan, Patrick $u Department of Neuroscience, Central Clinical School, Monash University Faculty of Medicine Nursing and Health Sciences, Melbourne, Victoria, Australia
- 700 1_
- $a Laing, Joshua Andrew $u Neurology, Alfred Hospital, Melbourne, Victoria, Australia
- 700 1_
- $a Leitinger, Markus $u Neurology, Paracelsus Medical University Salzburg, Salzburg, Austria
- 700 1_
- $a Lhatoo, Samden $u Neurology, University of Texas McGovern Medical School, Houston, Texas, USA
- 700 1_
- $a Makhalova, Julia $u Neurology, Aix-Marseille Universite, Marseille, France
- 700 1_
- $a McGonigal, Aileen $u Neurosciences, Mater Hospital Brisbane, Brisbane, Queensland, Australia $u UQ Faculty of Medicine, Herston, Queensland, Australia $1 https://orcid.org/0000000167755318
- 700 1_
- $a Mindruta, Iona $u Neurology, University of Medicine and Pharmacy Carol Davila Bucharest, Bucuresti, Romania
- 700 1_
- $a Mizera, Mary Margaret $u Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- 700 1_
- $a Neal, Andrew $u Neurology, Alfred Hospital, Melbourne, Victoria, Australia
- 700 1_
- $a Oane, Irina $u Neurology, University of Medicine and Pharmacy Carol Davila Bucharest, Bucuresti, Romania
- 700 1_
- $a Parikh, Prachi $u Neurology, Duke University, Durham, North Carolina, USA
- 700 1_
- $a Perucca, Piero $u Monash University, Clayton, Victoria, Australia
- 700 1_
- $a Pizzo, Francesca $u Neurology, Aix-Marseille Universite, Marseille, France
- 700 1_
- $a Rocamora, Rodrigo $u Neurology, Hospital del Mar, Barcelona, Spain
- 700 1_
- $a Ryvlin, Philippe $u Institute for Child and Adolescent with Epilepsy (IDEE), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
- 700 1_
- $a San Antonio Arce, Victoria $u Epilepsy Centre, University Hospital Freiburg Department of Neurology, Freiburg im Breisgau, Germany
- 700 1_
- $a Schuele, Stephan $u Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- 700 1_
- $a Schulze-Bonhage, Andreas $u Epilepsy Centre, University Hospital Freiburg Department of Neurology, Freiburg im Breisgau, Germany
- 700 1_
- $a Suller Marti, Ana $u Neurology, Western University Schulich School of Medicine & Dentistry, London, Ontario, Canada
- 700 1_
- $a Urban, Alexandra $u Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- 700 1_
- $a Villanueva, Vincente $u Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
- 700 1_
- $a Vilella Bertran, Laura $u Neurology, Hospital del Mar, Barcelona, Spain
- 700 1_
- $a Whatley, Benjamin $u Neurology, Dalhousie University Faculty of Medicine, Halifax, Nova Scotia, Canada
- 700 1_
- $a Beniczky, Sandor $u Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark
- 700 1_
- $a Trinka, Eugen $u Neurology, Paracelsus Medical University Salzburg, Salzburg, Austria
- 700 1_
- $a Zimmermann, Georg $u Biostatistics and Big Medical Data, Paracelsus Medical Private University, Salzburg, Austria
- 700 1_
- $a Frauscher, Birgit $u Neurology, Duke University, Durham, North Carolina, USA $u Neurology, Montreal Neurological Institute-Hospital, Montreal, Quebec, Canada
- 773 0_
- $w MED00215629 $t BMJ neurology open $x 2632-6140 $g Roč. 6, č. 2 (2024), s. e000765
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39175939 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241008 $b ABA008
- 991 __
- $a 20241016081805 $b ABA008
- 999 __
- $a ok $b bmc $g 2196432 $s 1229942
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 6 $c 2 $d e000765 $e 20240821 $i 2632-6140 $m BMJ neurology open $n BMJ Neurol Open $x MED00215629
- LZP __
- $a Pubmed-20241008